Sulfasalazine
Generic name: Pronounced as (sul fa sal' a zeen)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 01/15/2022
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Drug interactions
Why is this medication prescribed?
Sulfasalazine is used to treat ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) and also to maintain improvement of ulcerative colitis symptoms. Sulfasalazine delayed-release (Azulfidine EN-tabs) is also used to treat rheumatoid arthritis in adults whose disease has not responded well to other medications or could not be tolerated. Sulfasalazine delayed-release (Azulfidine EN-tabs) is also used to treat polyarticular juvenile idiopathic arthritis (PJIA; a type of childhood arthritis that affects five or more joints during the first six months of the condition, causing pain, swelling, and loss of function) in children who have not been helped by other medications. Sulfasalazine is in a class of medications called anti-inflammatory drugs. It works by reducing inflammation (swelling) inside the body.
How should this medicine be used?
Sulfasalazine comes as regular and delayed-release (releases the medication in the intestine to prevent irritation to the stomach and to allow the medication to work in the intestine where its effects are needed) tablets. It usually is taken 3 to 6 times a day in evenly spaced doses throughout the day so that no more than 8 hours separates any two doses, if possible. For treatment of rheumatoid arthritis or polyarticular juvenile idiopathic arthritis, sulfasalazine delayed-release tablets are usually taken twice a day in evenly spaced doses throughout the day. Take sulfasalazine after a meal or with a light snack, then drink a full glass of water. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take sulfasalazine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow delayed-release tablets whole; do not crush or chew them.
Drink plenty of fluids while taking sulfasalazine.
Continue to take sulfasalazine even if you feel well. Do not stop taking sulfasalazine without talking to your doctor.
Other uses for this medicine
Sulfasalazine is also used to treat bowel inflammation, diarrhea (stool frequency), rectal bleeding, and abdominal pain in Crohn's disease. Talk to your doctor about the possible risks of using this drug for your condition.
What special precautions should I follow?
Before taking sulfasalazine,
-
tell your doctor if you are allergic to sulfasalazine; sulfapyridine; salicylate pain relievers such as aspirin, choline magnesium trisalicylate, diflunisal, magnesium salicylate (Doan's, others); balsalazide (Colazal); mesalamine (Asacol, Pentasa, Rowasa, others); olsalazine (Dipentum); sulfa drugs; any other medications; or the ingredients in sulfasalzine tablets or delayed-release tablets. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: digoxin (Lanoxin), folic acid, and methotrexate (Trexall, Xatmep).
-
tell your doctor if you have or have ever had an intestinal obstruction (a blockage in your intestine), a urinary obstruction (a blockage of urine flowing out of the bladder), or porphyria (condition in which abnormal substances build up in the blood and cause problems with the skin or nervous system). Your doctor will probably tell you not to take sulfasalazine.
-
tell your doctor if you have an infection or if you have or have ever had an infection that keeps coming back. Also tell your doctor if you have or have ever had asthma, glucose-6-phosphate dehydrogenase (G-6-PD) deficiency (an inherited blood disease), kidney stones, blood problems, or kidney or liver disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking sulfasalazine, call your doctor.
-
you should know that this medication may decrease fertility in men. Fertility usually returns when the medicine is stopped. Talk to your doctor about the risks of taking sulfasalazine.
-
plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen. Sulfasalazine may make your skin sensitive to sunlight.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Sulfasalazine may cause side effects.
-
Tell your doctor if any of these symptoms are severe or do not go away:
-
yellow or orange discoloration of urine or skin
-
diarrhea
-
headache
-
loss of appetite
-
upset stomach
-
vomiting
-
stomach pain
-
-
If you have any of the following symptoms, stop taking sulfasalazine and call your doctor immediately:
-
rash, hives, itching or peeling or blistering skin
-
swelling of the eyes, face, lips, tongue, mouth, or throat
-
difficulty breathing or swallowing
-
swollen glands
-
fever, sore throat, chills, cough, night sweats, and other signs of infection
-
pale skin, tiredness, or shortness of breath
-
joint or muscle aches
-
yellowing of the skin or eyes
-
pain in the right upper part of the stomach
-
difficult or painful urination or cloudy, discolored or blood urine
-
chest pain
-
new or worsening cough
-
tiredness
-
unusual bleeding or bruising
-
weakness
-
seizures
-
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include the following:
-
nausea
-
vomiting
-
stomach pain
-
tiredness
-
seizures
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your response to sulfasalazine.
Do not let anyone else take your medicine. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Moxifloxacin | Moxifloxacin Sulfasalazine may increase the neuroexcitatory activities of Moxifloxacin. |
Repaglinide | Repaglinide Sulfasalazine may increase the hypoglycemic activities of Repaglinide. |
Insulin Glargine (rDNA origin) Injection | Insulin Glargine (rDNA origin) Injection Sulfasalazine may increase the hypoglycemic activities of Insulin glargine. |
Leflunomide | Leflunomide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Leflunomide. |
Atorvastatin | Atorvastatin The excretion of Atorvastatin can be decreased when combined with Sulfasalazine. |
Alendronate | Alendronate The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Alendronic acid. |
Anagrelide | Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Sulfasalazine. |
Candesartan | Candesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Sulfasalazine. |
Cilostazol | Cilostazol The risk or severity of bleeding can be increased when Sulfasalazine is combined with Cilostazol. |
Clopidogrel | Clopidogrel The risk or severity of bleeding can be increased when Sulfasalazine is combined with Clopidogrel. |
Erythromycin and Sulfisoxazole | Erythromycin and Sulfisoxazole The excretion of Erythromycin can be decreased when combined with Sulfasalazine. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Sulfasalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate Sulfasalazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Sulfasalazine. |
Magnesium Hydroxide | Magnesium Hydroxide Sulfasalazine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Methylergonovine | Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Sulfasalazine. |
Miglitol | Miglitol Sulfasalazine may increase the hypoglycemic activities of Miglitol. |
Mycophenolate | Mycophenolate The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mycophenolic acid. |
Naratriptan | Naratriptan The risk or severity of hypertension can be increased when Sulfasalazine is combined with Naratriptan. |
Olsalazine | Olsalazine The therapeutic efficacy of Olsalazine can be decreased when used in combination with Sulfasalazine. |
Penbutolol | Penbutolol Sulfasalazine may decrease the antihypertensive activities of Acebutolol. |
Potassium | Potassium Sulfasalazine may decrease the excretion rate of Potassium cation which could result in a higher serum level. |
Prednisone | Prednisone The risk or severity of gastrointestinal irritation can be increased when Prednisone is combined with Sulfasalazine. |
Ranitidine | Ranitidine Sulfasalazine may decrease the excretion rate of Ranitidine which could result in a higher serum level. |
Reserpine | Reserpine The therapeutic efficacy of Reserpine can be decreased when used in combination with Sulfasalazine. |
Rizatriptan | Rizatriptan Sulfasalazine may decrease the excretion rate of Rizatriptan which could result in a higher serum level. |
Sumatriptan | Sumatriptan Sulfasalazine may decrease the excretion rate of Sumatriptan which could result in a higher serum level. |
Tacrolimus | Tacrolimus The risk or severity of renal failure can be increased when Sulfasalazine is combined with Tacrolimus. |
Tiludronate | Tiludronate The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Etidronic acid. |
Triamcinolone | Triamcinolone The risk or severity of gastrointestinal irritation can be increased when Triamcinolone is combined with Sulfasalazine. |
Zolmitriptan | Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Sulfasalazine. |
Ampicillin Injection | Ampicillin Injection Sulfasalazine may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Sulfasalazine may decrease the excretion rate of Doxycycline which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection Sulfasalazine may decrease the excretion rate of Fluconazole which could result in a higher serum level. |
Foscarnet Injection | Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Foscarnet. |
Hydromorphone Injection | Hydromorphone Injection Sulfasalazine may decrease the excretion rate of Hydromorphone which could result in a higher serum level. |
Interferon Beta-1b Injection | Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Sulfasalazine. |
Interferon Gamma-1b Injection | Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sulfasalazine. |
Levofloxacin Injection | Levofloxacin Injection Sulfasalazine may decrease the excretion rate of Levofloxacin which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection Sulfasalazine may decrease the excretion rate of Meperidine which could result in a higher serum level. |
Methylprednisolone Injection | Methylprednisolone Injection The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Methylprednisolone. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Metoclopramide. |
Pamidronate Injection | Pamidronate Injection The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Pamidronic acid. |
Vancomycin Injection | Vancomycin Injection Sulfasalazine may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The risk or severity of bleeding can be increased when Zidovudine is combined with Sulfasalazine. |
Altretamine | Altretamine Sulfasalazine may decrease the excretion rate of Amphetamine which could result in a higher serum level. |
Cefuroxime | Cefuroxime The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefuroxime. |
Cyclosporine | Cyclosporine Sulfasalazine may increase the immunosuppressive activities of Cyclosporine. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Enoxaparin. |
Torsemide | Torsemide The therapeutic efficacy of Torasemide can be decreased when used in combination with Sulfasalazine. |
Eprosartan | Eprosartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Sulfasalazine. |
Hydroxychloroquine | Hydroxychloroquine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Hydroxychloroquine. |
Meloxicam | Meloxicam The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Meloxicam. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Risedronate | Risedronate The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Risedronic acid. |
Sevelamer | Sevelamer Sevelamer can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Telmisartan | Telmisartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Sulfasalazine. |
Temozolomide | Temozolomide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Temozolomide. |
Zaleplon | Zaleplon Sulfasalazine may decrease the excretion rate of Zaleplon which could result in a higher serum level. |
Anakinra | Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Sulfasalazine. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Sulfasalazine. |
Pentosan Polysulfate | Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Pentosan polysulfate. |
Trimipramine | Trimipramine The risk or severity of hypertension can be increased when Trimipramine is combined with Sulfasalazine. |
Etanercept Injection | Etanercept Injection The risk or severity of neutropenia can be increased when Etanercept is combined with Sulfasalazine. |
Perindopril | Perindopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Perindopril. |
Tenofovir | Tenofovir Sulfasalazine may increase the nephrotoxic activities of Tenofovir. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Choline magnesium trisalicylate. |
Sirolimus | Sirolimus The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Sirolimus. |
Dutasteride | Dutasteride The risk or severity of hypertension can be increased when Sulfasalazine is combined with Dutasteride. |
Epinephrine Injection | Epinephrine Injection The risk or severity of hypertension can be increased when Epinephrine is combined with Sulfasalazine. |
Epirubicin | Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Sulfasalazine. |
Eplerenone | Eplerenone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Eplerenone. |
Escitalopram | Escitalopram The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Sulfasalazine. |
Olmesartan | Olmesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Sulfasalazine. |
Zonisamide | Zonisamide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Zonisamide. |
Adalimumab Injection | Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Sulfasalazine. |
Aripiprazole | Aripiprazole The risk or severity of hypertension can be increased when Sulfasalazine is combined with Aripiprazole. |
Atomoxetine | Atomoxetine Sulfasalazine may decrease the excretion rate of Atomoxetine which could result in a higher serum level. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of hypertension can be increased when Sulfasalazine is combined with Dexmethylphenidate. |
Ezetimibe | Ezetimibe Sulfasalazine may decrease the excretion rate of Ezetimibe which could result in a higher serum level. |
Glatiramer Injection | Glatiramer Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Glatiramer. |
Atazanavir | Atazanavir The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Atazanavir. |
Almotriptan | Almotriptan Sulfasalazine may decrease the excretion rate of Almotriptan which could result in a higher serum level. |
Eletriptan | Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Sulfasalazine. |
Rosuvastatin | Rosuvastatin Sulfasalazine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level. |
Emtricitabine | Emtricitabine Sulfasalazine may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine Sulfasalazine may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tegaserod | Tegaserod Sulfasalazine may decrease the excretion rate of Tegaserod which could result in a higher serum level. |
Tadalafil | Tadalafil Sulfasalazine may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Frovatriptan | Frovatriptan The risk or severity of hypertension can be increased when Sulfasalazine is combined with Frovatriptan. |
Gemifloxacin | Gemifloxacin Sulfasalazine may increase the neuroexcitatory activities of Gemifloxacin. |
Progesterone | Progesterone Progesterone may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Infliximab Injection | Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Sulfasalazine. |
Protriptyline | Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Sulfasalazine. |
Duloxetine | Duloxetine The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Sulfasalazine. |
Tinidazole | Tinidazole Sulfasalazine may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Bosentan | Bosentan The therapeutic efficacy of Bosentan can be decreased when used in combination with Sulfasalazine. |
Cefditoren | Cefditoren Sulfasalazine may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Natalizumab Injection | Natalizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Natalizumab. |
Cyanocobalamin Injection | Cyanocobalamin Injection Sulfasalazine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level. |
Erlotinib | Erlotinib Erlotinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Eszopiclone | Eszopiclone Sulfasalazine may decrease the excretion rate of Eszopiclone which could result in a higher serum level. |
Ganciclovir | Ganciclovir Sulfasalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Insulin Aspart (rDNA Origin) Injection | Insulin Aspart (rDNA Origin) Injection Sulfasalazine may increase the hypoglycemic activities of Insulin aspart. |
Ribavirin | Ribavirin Sulfasalazine may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Solifenacin | Solifenacin The risk or severity of hypertension can be increased when Sulfasalazine is combined with Solifenacin. |
Valganciclovir | Valganciclovir Sulfasalazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Zoledronic Acid Injection | Zoledronic Acid Injection The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Zoledronic acid. |
Adefovir | Adefovir The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Adefovir. |
Dextroamphetamine | Dextroamphetamine Sulfasalazine may decrease the excretion rate of Amphetamine which could result in a higher serum level. |
Peginterferon Alfa-2a Injection | Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Sulfasalazine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sulfasalazine. |
Pramlintide Injection | Pramlintide Injection Sulfasalazine may increase the hypoglycemic activities of Pramlintide. |
Exenatide Injection | Exenatide Injection Sulfasalazine may increase the hypoglycemic activities of Exenatide. |
Ibandronate | Ibandronate The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Ibandronate. |
Isocarboxazid | Isocarboxazid The risk or severity of hypertension can be increased when Sulfasalazine is combined with Isocarboxazid. |
Ramelteon | Ramelteon Sulfasalazine may decrease the excretion rate of Ramelteon which could result in a higher serum level. |
Fentanyl | Fentanyl Sulfasalazine may decrease the excretion rate of Fentanyl which could result in a higher serum level. |
Pregabalin | Pregabalin Sulfasalazine may decrease the excretion rate of Pregabalin which could result in a higher serum level. |
Deferasirox | Deferasirox The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Sulfasalazine is combined with Deferasirox. |
Phenylephrine | Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Sulfasalazine. |
Insulin Detemir (rDNA Origin) Injection | Insulin Detemir (rDNA Origin) Injection Sulfasalazine may increase the hypoglycemic activities of Insulin detemir. |
Ranolazine | Ranolazine Sulfasalazine may decrease the excretion rate of Ranolazine which could result in a higher serum level. |
Abatacept Injection | Abatacept Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Abatacept. |
Rasagiline | Rasagiline Sulfasalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level. |
Imatinib | Imatinib The risk or severity of adverse effects can be increased when Imatinib is combined with Sulfasalazine. |
Sitagliptin | Sitagliptin Sulfasalazine may increase the hypoglycemic activities of Sitagliptin. |
Varenicline | Varenicline Sulfasalazine may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Bevacizumab Injection | Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Sulfasalazine. |
Gefitinib | Gefitinib Gefitinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Albuterol | Albuterol Sulfasalazine may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone Sulfasalazine may decrease the excretion rate of Paliperidone which could result in a higher serum level. |
Bortezomib | Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Sulfasalazine. |
Clofarabine Injection | Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Sulfasalazine. |
Hepatitis B Vaccine | Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Sulfasalazine. |
Influenza Vaccine, Inactivated or Recombinant | Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Sulfasalazine. |
Influenza Vaccine, Live Intranasal | Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Sulfasalazine. |
Live Shingles (Zoster) Vaccine (ZVL) | Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Sulfasalazine. |
Insulin Glulisine (rDNA origin) Injection | Insulin Glulisine (rDNA origin) Injection Sulfasalazine may increase the hypoglycemic activities of Insulin glulisine. |
Lubiprostone | Lubiprostone Sulfasalazine may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Sulfasalazine. |
Primaquine | Primaquine The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Primaquine. |
Rituximab Injection | Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Sulfasalazine. |
Aliskiren | Aliskiren The risk or severity of renal failure and hypertension can be increased when Sulfasalazine is combined with Aliskiren. |
Bismuth Subsalicylate | Bismuth Subsalicylate The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Sulfasalazine. |
Pemetrexed Injection | Pemetrexed Injection Sulfasalazine may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Lisdexamfetamine | Lisdexamfetamine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Lisdexamfetamine. |
Vorinostat | Vorinostat The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Vorinostat. |
Sorafenib | Sorafenib The risk or severity of adverse effects can be increased when Sorafenib is combined with Sulfasalazine. |
Sunitinib | Sunitinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Sunitinib. |
Dronabinol | Dronabinol Dronabinol may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Levocetirizine | Levocetirizine Sulfasalazine may decrease the excretion rate of Levocetirizine which could result in a higher serum level. |
Pegaptanib Injection | Pegaptanib Injection Sulfasalazine may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dasatinib. |
Azacitidine Injection | Azacitidine Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Azacitidine. |
Ivermectin | Ivermectin Sulfasalazine may decrease the excretion rate of Ivermectin which could result in a higher serum level. |
Temsirolimus | Temsirolimus The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Temsirolimus. |
Antipyrine-Benzocaine Otic | Antipyrine-Benzocaine Otic The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Benzocaine. |
Nelarabine Injection | Nelarabine Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Nelarabine. |
Lenalidomide | Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Sulfasalazine. |
Nilotinib | Nilotinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Nilotinib. |
Bexarotene | Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Sulfasalazine. |
Budesonide | Budesonide The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Budesonide. |
Chloramphenicol Injection | Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Sulfasalazine. |
Decitabine Injection | Decitabine Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Decitabine. |
Desmopressin | Desmopressin The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Sulfasalazine is combined with Desmopressin. |
Doripenem Injection | Doripenem Injection Sulfasalazine may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Arsenic trioxide. |
Mitoxantrone Injection | Mitoxantrone Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mitoxantrone. |
Desvenlafaxine | Desvenlafaxine The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Sulfasalazine. |
Cevimeline | Cevimeline Sulfasalazine may decrease the excretion rate of Cevimeline which could result in a higher serum level. |
Nebivolol | Nebivolol Sulfasalazine may decrease the antihypertensive activities of Nebivolol. |
Tretinoin | Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Sulfasalazine. |
Bendamustine Injection | Bendamustine Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Bendamustine. |
Leucovorin Injection | Leucovorin Injection The serum concentration of Leucovorin can be decreased when it is combined with Sulfasalazine. |
Certolizumab Injection | Certolizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Certolizumab pegol. |
Ixabepilone Injection | Ixabepilone Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ixabepilone. |
Irinotecan Injection | Irinotecan Injection The risk or severity of adverse effects can be increased when Irinotecan is combined with Sulfasalazine. |
Levoleucovorin Injection | Levoleucovorin Injection The serum concentration of Levoleucovorin can be decreased when it is combined with Sulfasalazine. |
Daptomycin Injection | Daptomycin Injection Sulfasalazine may decrease the excretion rate of Daptomycin which could result in a higher serum level. |
Estramustine | Estramustine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Estramustine. |
Methylnaltrexone Injection | Methylnaltrexone Injection Sulfasalazine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) | Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Sulfasalazine. |
Midazolam | Midazolam Sulfasalazine may decrease the excretion rate of Midazolam which could result in a higher serum level. |
Dexrazoxane Injection | Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Sulfasalazine. |
Eltrombopag | Eltrombopag Eltrombopag may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Ibritumomab Injection | Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Sulfasalazine. |
Milnacipran | Milnacipran The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Sulfasalazine. |
Plerixafor Injection | Plerixafor Injection Sulfasalazine may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Sodium Phosphate | Sodium Phosphate The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Sulfasalazine. |
Fesoterodine | Fesoterodine Sulfasalazine may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Betaxolol | Betaxolol Sulfasalazine may decrease the antihypertensive activities of Betaxolol. |
Iloperidone | Iloperidone The risk or severity of hypertension can be increased when Sulfasalazine is combined with Iloperidone. |
Prasugrel | Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Prasugrel. |
Everolimus | Everolimus The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Tolvaptan. |
Dronedarone | Dronedarone The risk or severity of hypertension can be increased when Sulfasalazine is combined with Dronedarone. |
Pralatrexate Injection | Pralatrexate Injection The serum concentration of Pralatrexate can be increased when it is combined with Sulfasalazine. |
Palonosetron Injection | Palonosetron Injection Sulfasalazine may decrease the excretion rate of Palonosetron which could result in a higher serum level. |
Saxagliptin | Saxagliptin Sulfasalazine may increase the hypoglycemic activities of Saxagliptin. |
Telavancin Injection | Telavancin Injection Sulfasalazine may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Romidepsin Injection | Romidepsin Injection The excretion of Romidepsin can be decreased when combined with Sulfasalazine. |
Topotecan | Topotecan The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Topotecan. |
Golimumab Injection | Golimumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Golimumab. |
Pazopanib | Pazopanib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pazopanib. |
Asenapine | Asenapine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Asenapine. |
Pitavastatin | Pitavastatin Sulfasalazine may decrease the excretion rate of Pitavastatin which could result in a higher serum level. |
Denosumab Injection | Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Sulfasalazine. |
Dabigatran | Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Dabigatran. |
Liraglutide Injection | Liraglutide Injection Sulfasalazine may increase the hypoglycemic activities of Liraglutide. |
Tocilizumab Injection | Tocilizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tocilizumab. |
Dalfampridine | Dalfampridine Sulfasalazine may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
Fingolimod | Fingolimod Sulfasalazine may increase the immunosuppressive activities of Fingolimod. |
Eribulin Injection | Eribulin Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Eribulin. |
Cabazitaxel Injection | Cabazitaxel Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Cabazitaxel. |
Ceftaroline Injection | Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Ceftaroline fosamil. |
Lurasidone | Lurasidone The risk or severity of hypertension can be increased when Sulfasalazine is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The risk or severity of adverse effects can be increased when Acetaminophen is combined with Sulfasalazine. |
Vilazodone | Vilazodone The risk or severity of hypertension can be increased when Sulfasalazine is combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Sulfasalazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sulfasalazine. |
Sipuleucel-T Injection | Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Sulfasalazine. |
Terbutaline Injection | Terbutaline Injection Sulfasalazine may decrease the excretion rate of Terbutaline which could result in a higher serum level. |
Belimumab Injection | Belimumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Belimumab. |
Azilsartan | Azilsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Sulfasalazine. |
Busulfan Injection | Busulfan Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Busulfan. |
Roflumilast | Roflumilast Roflumilast may increase the immunosuppressive activities of Sulfasalazine. |
Linagliptin | Linagliptin Sulfasalazine may increase the hypoglycemic activities of Linagliptin. |
Rilpivirine | Rilpivirine Rilpivirine may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Telaprevir | Telaprevir Sulfasalazine may decrease the excretion rate of Glecaprevir which could result in a higher serum level. |
Potassium Iodide | Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Sulfasalazine. |
Cyclophosphamide Injection | Cyclophosphamide Injection The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Sulfasalazine. |
Rivaroxaban | Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Rivaroxaban. |
Ticagrelor | Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Ticagrelor. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Brentuximab vedotin. |
Ruxolitinib | Ruxolitinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ruxolitinib. |
Vandetanib | Vandetanib Vandetanib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Clobazam | Clobazam Sulfasalazine may decrease the excretion rate of Clobazam which could result in a higher serum level. |
Vemurafenib | Vemurafenib Sulfasalazine may decrease the excretion rate of Vemurafenib which could result in a higher serum level. |
Vismodegib | Vismodegib Vismodegib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Belatacept Injection | Belatacept Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Belatacept. |
Basiliximab Injection | Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Sulfasalazine. |
Deferiprone | Deferiprone Sulfasalazine may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Axitinib | Axitinib The excretion of Axitinib can be decreased when combined with Sulfasalazine. |
Melphalan Injection | Melphalan Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Melphalan. |
Cabergoline | Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Sulfasalazine. |
Naloxone Injection | Naloxone Injection Sulfasalazine may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Ambrisentan | Ambrisentan The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Sulfasalazine. |
Eculizumab Injection | Eculizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Eculizumab. |
Fondaparinux Injection | Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Fondaparinux. |
Carfilzomib Injection | Carfilzomib Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Carfilzomib. |
Iloprost | Iloprost The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Iloprost. |
Enzalutamide | Enzalutamide Sulfasalazine may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron Sulfasalazine may decrease the excretion rate of Mirabegron which could result in a higher serum level. |
Regorafenib | Regorafenib Regorafenib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Bosutinib | Bosutinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Bosutinib. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Corticotropin. |
Teriflunomide | Teriflunomide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Teriflunomide. |
Lorcaserin | Lorcaserin Sulfasalazine may increase the hypoglycemic activities of Mecasermin. |
Teduglutide Injection | Teduglutide Injection Sulfasalazine may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Icosapent Ethyl | Icosapent Ethyl The risk or severity of bleeding can be increased when Sulfasalazine is combined with Icosapent ethyl. |
Tofacitinib | Tofacitinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tofacitinib. |
Alogliptin | Alogliptin Sulfasalazine may increase the hypoglycemic activities of Alogliptin. |
Dimethyl Fumarate | Dimethyl Fumarate The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dimethyl fumarate. |
Ponatinib | Ponatinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ponatinib. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pomalidomide. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Trastuzumab emtansine. |
Apixaban | Apixaban The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Apixaban. |
Canagliflozin | Canagliflozin Sulfasalazine may increase the hypoglycemic activities of Canagliflozin. |
Methazolamide | Methazolamide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Methazolamide. |
Dabrafenib | Dabrafenib Sulfasalazine may decrease the excretion rate of Dabrafenib which could result in a higher serum level. |
Trametinib | Trametinib Sulfasalazine may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Dolutegravir | Dolutegravir Sulfasalazine may decrease the excretion rate of Dolutegravir which could result in a higher serum level. |
Afatinib | Afatinib Sulfasalazine may decrease the excretion rate of Afatinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Sulfasalazine. |
Ertapenem Injection | Ertapenem Injection Sulfasalazine may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine Sulfasalazine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ibrutinib | Ibrutinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibrutinib. |
Ketorolac Injection | Ketorolac Injection The risk or severity of adverse effects can be increased when Ketorolac is combined with Sulfasalazine. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Obinutuzumab. |
Simeprevir | Simeprevir Sulfasalazine may decrease the excretion rate of Simeprevir which could result in a higher serum level. |
Sofosbuvir | Sofosbuvir Sulfasalazine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Sulfasalazine may increase the hypoglycemic activities of Dapagliflozin. |
Apremilast | Apremilast The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Apremilast. |
Droxidopa | Droxidopa Sulfasalazine may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Siltuximab Injection | Siltuximab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Siltuximab. |
Albiglutide Injection | Albiglutide Injection Sulfasalazine may increase the hypoglycemic activities of Albiglutide. |
Vedolizumab Injection | Vedolizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Vedolizumab. |
Belinostat Injection | Belinostat Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Belinostat. |
Idelalisib | Idelalisib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Idelalisib. |
Testosterone Injection | Testosterone Injection Sulfasalazine may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Empagliflozin | Empagliflozin Sulfasalazine may increase the hypoglycemic activities of Empagliflozin. |
Vorapaxar | Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Vorapaxar. |
Dulaglutide Injection | Dulaglutide Injection Sulfasalazine may increase the hypoglycemic activities of Dulaglutide. |
Edoxaban | Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Edoxaban. |
Peginterferon Beta-1a Injection | Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Peginterferon beta-1a. |
Olaparib | Olaparib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Olaparib. |
Blinatumomab Injection | Blinatumomab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Blinatumomab. |
Caspofungin Injection | Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Sulfasalazine. |
Methamphetamine | Methamphetamine Sulfasalazine may decrease the excretion rate of Metamfetamine which could result in a higher serum level. |
Tasimelteon | Tasimelteon Sulfasalazine may decrease the excretion rate of Tasimelteon which could result in a higher serum level. |
Riociguat | Riociguat Sulfasalazine may decrease the excretion rate of Riociguat which could result in a higher serum level. |
Pirfenidone | Pirfenidone The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pirfenidone. |
Secukinumab Injection | Secukinumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Secukinumab. |
Risperidone Injection | Risperidone Injection The risk or severity of hypertension can be increased when Risperidone is combined with Sulfasalazine. |
Palbociclib | Palbociclib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Palbociclib. |
Insulin Human Inhalation | Insulin Human Inhalation Sulfasalazine may increase the hypoglycemic activities of Insulin human. |
Lenvatinib | Lenvatinib Sulfasalazine may decrease the excretion rate of Lenvatinib which could result in a higher serum level. |
Panobinostat | Panobinostat The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Panobinostat. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The therapeutic efficacy of Haloperidol can be increased when used in combination with Sulfasalazine. |
Amiloride | Amiloride The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Amiloride. |
Macitentan | Macitentan The therapeutic efficacy of Macitentan can be decreased when used in combination with Sulfasalazine. |
Flibanserin | Flibanserin The risk or severity of hypertension can be increased when Sulfasalazine is combined with Flibanserin. |
Rolapitant | Rolapitant Rolapitant may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Prednisolone | Prednisolone The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Prednisolone. |
Daclatasvir | Daclatasvir Daclatasvir may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Brexpiprazole | Brexpiprazole The risk or severity of hypertension can be increased when Sulfasalazine is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of hypertension can be increased when Ziprasidone is combined with Sulfasalazine. |
Cariprazine | Cariprazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Cariprazine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Sulfasalazine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Eluxadoline | Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Sulfasalazine. |
Insulin Degludec (rDNA Origin) Injection | Insulin Degludec (rDNA Origin) Injection Sulfasalazine may increase the hypoglycemic activities of Insulin degludec. |
Cobimetinib | Cobimetinib The excretion of Cobimetinib can be decreased when combined with Sulfasalazine. |
Mepolizumab Injection | Mepolizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mepolizumab. |
Trabectedin Injection | Trabectedin Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Trabectedin. |
Osimertinib | Osimertinib Sulfasalazine may decrease the excretion rate of Osimertinib which could result in a higher serum level. |
Alectinib | Alectinib Alectinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Ixazomib | Ixazomib Sulfasalazine may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Sulfasalazine may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Sulfasalazine. |
Dexamethasone Injection | Dexamethasone Injection The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Dexamethasone. |
Defibrotide Injection | Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Defibrotide. |
Ixekizumab Injection | Ixekizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ixekizumab. |
Brivaracetam Injection | Brivaracetam Injection Sulfasalazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level. |
Venetoclax | Venetoclax Sulfasalazine may decrease the excretion rate of Venetoclax which could result in a higher serum level. |
Cobicistat | Cobicistat Cobicistat may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Midodrine | Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Sulfasalazine. |
Selexipag | Selexipag The therapeutic efficacy of Selexipag can be decreased when used in combination with Sulfasalazine. |
Furosemide Injection | Furosemide Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Furosemide. |
Rucaparib | Rucaparib Sulfasalazine may decrease the excretion rate of Rucaparib which could result in a higher serum level. |
Lixisenatide Injection | Lixisenatide Injection Sulfasalazine may increase the hypoglycemic activities of Lixisenatide. |
Brodalumab Injection | Brodalumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Brodalumab. |
Brigatinib | Brigatinib Sulfasalazine may decrease the excretion rate of Brigatinib which could result in a higher serum level. |
Doxepin (Insomnia) | Doxepin (Insomnia) Sulfasalazine may decrease the excretion rate of Doxepin which could result in a higher serum level. |
Deutetrabenazine | Deutetrabenazine Sulfasalazine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. |
Valbenazine | Valbenazine Sulfasalazine may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Deflazacort. |
Safinamide | Safinamide Safinamide may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Ocrelizumab Injection | Ocrelizumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ocrelizumab. |
Naldemedine | Naldemedine Sulfasalazine may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Sarilumab Injection | Sarilumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Sarilumab. |
Guselkumab Injection | Guselkumab Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Guselkumab. |
Enasidenib | Enasidenib Sulfasalazine may decrease the excretion rate of Enasidenib which could result in a higher serum level. |
Benznidazole | Benznidazole Sulfasalazine may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Copanlisib Injection | Copanlisib Injection Sulfasalazine may decrease the excretion rate of Copanlisib which could result in a higher serum level. |
Delafloxacin | Delafloxacin Sulfasalazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Abemaciclib | Abemaciclib Sulfasalazine may decrease the excretion rate of Abemaciclib which could result in a higher serum level. |
Betrixaban | Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Sulfasalazine. |
Gemtuzumab Ozogamicin Injection | Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sulfasalazine. |
Letermovir | Letermovir Letermovir may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Semaglutide Injection | Semaglutide Injection Sulfasalazine may increase the hypoglycemic activities of Semaglutide. |
Ertugliflozin | Ertugliflozin Sulfasalazine may decrease the excretion rate of Ertugliflozin which could result in a higher serum level. |
Buprenorphine Injection | Buprenorphine Injection Buprenorphine may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Apalutamide | Apalutamide Sulfasalazine may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Penicillamine | Penicillamine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Penicillamine. |
Fostamatinib | Fostamatinib Fostamatinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Avatrombopag | Avatrombopag Avatrombopag may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Baricitinib | Baricitinib The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Baricitinib. |
Lofexidine | Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Sulfasalazine. |
Plazomicin Injection | Plazomicin Injection Sulfasalazine may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Lusutrombopag | Lusutrombopag Sulfasalazine may decrease the excretion rate of Lusutrombopag which could result in a higher serum level. |
Elagolix | Elagolix The excretion of Elagolix can be decreased when combined with Sulfasalazine. |
Cannabidiol | Cannabidiol Cannabidiol may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Dacomitinib | Dacomitinib Sulfasalazine may decrease the excretion rate of Dacomitinib which could result in a higher serum level. |
Duvelisib | Duvelisib Sulfasalazine may decrease the excretion rate of Duvelisib which could result in a higher serum level. |
Stiripentol | Stiripentol Sulfasalazine may decrease the excretion rate of Stiripentol which could result in a higher serum level. |
Talazoparib | Talazoparib Sulfasalazine may decrease the excretion rate of Talazoparib which could result in a higher serum level. |
Gilteritinib | Gilteritinib Gilteritinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Glasdegib | Glasdegib Sulfasalazine may decrease the excretion rate of Glasdegib which could result in a higher serum level. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Paclitaxel. |
Prucalopride | Prucalopride Sulfasalazine may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Ravulizumab-cwvz Injection | Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ravulizumab. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Emapalumab. |
Siponimod | Siponimod The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Siponimod. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Sulfasalazine may decrease the excretion rate of Acyclovir which could result in a higher serum level. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Sulfasalazine is combined with Caplacizumab. |
Risankizumab-rzaa Injection | Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Risankizumab. |
Alpelisib | Alpelisib The serum concentration of Alpelisib can be increased when it is combined with Sulfasalazine. |
Cladribine | Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Sulfasalazine. |
Solriamfetol | Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Sulfasalazine. |
Darolutamide | Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Sulfasalazine. |
Istradefylline | Istradefylline Istradefylline may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Pitolisant | Pitolisant The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pitolisant. |
Fedratinib | Fedratinib Fedratinib may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Phenytoin Injection | Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Sulfasalazine. |
Fosphenytoin Injection | Fosphenytoin Injection The protein binding of Fosphenytoin can be decreased when combined with Sulfasalazine. |
Lasmiditan | Lasmiditan The serum concentration of Sulfasalazine can be increased when it is combined with Lasmiditan. |
Ubrogepant | Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Sulfasalazine. |
Tazemetostat | Tazemetostat Sulfasalazine may decrease the excretion rate of Tazemetostat which could result in a higher serum level. |
Bempedoic Acid | Bempedoic Acid The excretion of Bempedoic acid can be decreased when combined with Sulfasalazine. |
Ozanimod | Ozanimod Sulfasalazine may decrease the excretion rate of Ozanimod which could result in a higher serum level. |
Selumetinib | Selumetinib Sulfasalazine may decrease the excretion rate of Selumetinib which could result in a higher serum level. |
Rimegepant | Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Sulfasalazine. |
Tucatinib | Tucatinib Sulfasalazine may decrease the excretion rate of Tucatinib which could result in a higher serum level. |
Remdesivir Injection | Remdesivir Injection The excretion of Remdesivir can be decreased when combined with Sulfasalazine. |
Ripretinib | Ripretinib Sulfasalazine may decrease the excretion rate of Ripretinib which could result in a higher serum level. |
Selpercatinib | Selpercatinib The risk or severity of hypertension can be increased when Sulfasalazine is combined with Selpercatinib. |
Capmatinib | Capmatinib The serum concentration of Sulfasalazine can be increased when it is combined with Capmatinib. |
Fostemsavir | Fostemsavir Sulfasalazine may decrease the excretion rate of Fostemsavir which could result in a higher serum level. |
Belantamab Mafodotin-blmf Injection | Belantamab Mafodotin-blmf Injection The excretion of Belantamab mafodotin can be decreased when combined with Sulfasalazine. |
Pralsetinib | Pralsetinib Sulfasalazine may decrease the excretion rate of Pralsetinib which could result in a higher serum level. |
Naxitamab-gqgk Injection | Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Sulfasalazine is combined with Naxitamab. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Drospirenone. |
Viloxazine | Viloxazine Sulfasalazine may decrease the excretion rate of Viloxazine which could result in a higher serum level. |
Tobramycin Injection | Tobramycin Injection Sulfasalazine may decrease the excretion rate of Tobramycin which could result in a higher serum level. |
Fenoprofen | Fenoprofen The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Fenoprofen. |
Indomethacin | Indomethacin The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Indomethacin. |
Mefenamic Acid | Mefenamic Acid The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Mefenamic acid. |
Naproxen | Naproxen The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Naproxen. |
Tolmetin | Tolmetin The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Tolmetin. |
Sulindac | Sulindac The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Sulindac. |
Trazodone | Trazodone The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Sulfasalazine. |
Isotretinoin | Isotretinoin Sulfasalazine may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Sulfasalazine may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Hydroxyurea | Hydroxyurea The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Hydroxyurea. |
Floxuridine | Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Sulfasalazine. |
Phenobarbital | Phenobarbital The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Phenobarbital. |
Metaxalone | Metaxalone Sulfasalazine may decrease the excretion rate of Metaxalone which could result in a higher serum level. |
Methotrexate Injection | Methotrexate Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Methotrexate. |
Methsuximide | Methsuximide The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of hypertension can be increased when Sulfasalazine is combined with Diethylpropion. |
Chlorpromazine | Chlorpromazine Sulfasalazine may decrease the excretion rate of Chlorpromazine which could result in a higher serum level. |
Diazepam | Diazepam Sulfasalazine may decrease the excretion rate of Diazepam which could result in a higher serum level. |
Oxazepam | Oxazepam Sulfasalazine may decrease the excretion rate of Oxazepam which could result in a higher serum level. |
Flurazepam | Flurazepam Sulfasalazine may decrease the excretion rate of Flurazepam which could result in a higher serum level. |
Clorazepate | Clorazepate Sulfasalazine may decrease the excretion rate of Clorazepic acid which could result in a higher serum level. |
Lorazepam | Lorazepam Sulfasalazine may decrease the excretion rate of Lorazepam which could result in a higher serum level. |
Phenoxybenzamine | Phenoxybenzamine The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Sulfasalazine. |
Carmustine | Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Sulfasalazine. |
Amantadine | Amantadine Sulfasalazine may decrease the excretion rate of Amantadine which could result in a higher serum level. |
Codeine | Codeine Sulfasalazine may decrease the excretion rate of Codeine which could result in a higher serum level. |
Bromocriptine | Bromocriptine Sulfasalazine may increase the hypoglycemic activities of Bromocriptine. |
Metaproterenol | Metaproterenol The risk or severity of hypertension can be increased when Sulfasalazine is combined with Orciprenaline. |
Tranylcypromine | Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Sulfasalazine. |
Phenelzine | Phenelzine Sulfasalazine may decrease the excretion rate of Phenelzine which could result in a higher serum level. |
Procarbazine | Procarbazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Procarbazine. |
Ergoloid Mesylates | Ergoloid Mesylates The risk or severity of hypertension can be increased when Sulfasalazine is combined with Ergoloid mesylate. |
Tetracycline | Tetracycline Sulfasalazine may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Thioguanine | Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Sulfasalazine. |
Thioridazine | Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Sulfasalazine. |
Trifluoperazine | Trifluoperazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Trifluoperazine. |
Bleomycin | Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Sulfasalazine. |
Dapsone | Dapsone The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Sulfasalazine. |
Sulfadiazine | Sulfadiazine The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Sulfadiazine. |
Methadone | Methadone Sulfasalazine may decrease the excretion rate of Methadone which could result in a higher serum level. |
Benztropine | Benztropine Sulfasalazine may decrease the excretion rate of Benzatropine which could result in a higher serum level. |
Colestipol | Colestipol Colestipol can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Maprotiline | Maprotiline Sulfasalazine may decrease the excretion rate of Maprotiline which could result in a higher serum level. |
Ibuprofen | Ibuprofen The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibuprofen. |
Azathioprine | Azathioprine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Azathioprine. |
Phentermine | Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Sulfasalazine. |
Methylphenidate | Methylphenidate Sulfasalazine may decrease the excretion rate of Methylphenidate which could result in a higher serum level. |
Amoxapine | Amoxapine The risk or severity of hypertension can be increased when Amoxapine is combined with Sulfasalazine. |
Hydrocortisone | Hydrocortisone The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Sulfasalazine. |
Lomustine | Lomustine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Lomustine. |
Doxorubicin | Doxorubicin The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Doxorubicin. |
Cytarabine | Cytarabine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Cytarabine. |
Mechlorethamine | Mechlorethamine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mechlorethamine. |
Dactinomycin | Dactinomycin The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dactinomycin. |
Phenazopyridine | Phenazopyridine The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Phenazopyridine. |
Carbamazepine | Carbamazepine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Carbamazepine. |
Methyldopa | Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Sulfasalazine. |
Clonidine | Clonidine The therapeutic efficacy of Clonidine can be decreased when used in combination with Sulfasalazine. |
Prazosin | Prazosin Sulfasalazine may decrease the excretion rate of Prazosin which could result in a higher serum level. |
Hydralazine | Hydralazine Sulfasalazine may decrease the antihypertensive activities of Hydralazine. |
Cimetidine | Cimetidine Sulfasalazine may decrease the excretion rate of Cimetidine which could result in a higher serum level. |
Gentamicin Injection | Gentamicin Injection Sulfasalazine may decrease the excretion rate of Gentamicin which could result in a higher serum level. |
Warfarin | Warfarin The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Warfarin. |
Clonazepam | Clonazepam Sulfasalazine may decrease the excretion rate of Clonazepam which could result in a higher serum level. |
Loperamide | Loperamide The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Loperamide. |
Promethazine | Promethazine Sulfasalazine may decrease the excretion rate of Promethazine which could result in a higher serum level. |
Meclofenamate | Meclofenamate The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Meclofenamic acid. |
Daunorubicin | Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Sulfasalazine. |
Nitrofurantoin | Nitrofurantoin The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Nitrofurantoin. |
Digoxin | Digoxin The serum concentration of Digoxin can be decreased when it is combined with Sulfasalazine. |
Chloroquine | Chloroquine The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Chloroquine. |
Quinine | Quinine The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Sulfasalazine. |
Triamterene | Triamterene The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Triamterene. |
Sulfinpyrazone | Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfasalazine is combined with Sulfinpyrazone. |
Chlorothiazide | Chlorothiazide The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Sulfasalazine. |
Chlorthalidone | Chlorthalidone The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Sulfasalazine. |
Metolazone | Metolazone The therapeutic efficacy of Metolazone can be decreased when used in combination with Sulfasalazine. |
Secobarbital | Secobarbital Sulfasalazine may decrease the excretion rate of Secobarbital which could result in a higher serum level. |
Desipramine | Desipramine Sulfasalazine may decrease the excretion rate of Desipramine which could result in a higher serum level. |
Amitriptyline | Amitriptyline Amitriptyline may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Imipramine | Imipramine Imipramine may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Probenecid | Probenecid Probenecid may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Quinidine | Quinidine Sulfasalazine may decrease the excretion rate of Quinidine which could result in a higher serum level. |
Procainamide | Procainamide Sulfasalazine may decrease the excretion rate of Procainamide which could result in a higher serum level. |
Isoniazid | Isoniazid Sulfasalazine may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Sulfasalazine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Rifampin | Rifampin The excretion of Rifampicin can be decreased when combined with Sulfasalazine. |
Disopyramide | Disopyramide Sulfasalazine may increase the hypoglycemic activities of Disopyramide. |
Valproic Acid | Valproic Acid The serum concentration of Valproic acid can be increased when it is combined with Sulfasalazine. |
Tamoxifen | Tamoxifen Sulfasalazine may decrease the excretion rate of Tamoxifen which could result in a higher serum level. |
Mitomycin | Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Sulfasalazine. |
Butabarbital | Butabarbital Sulfasalazine may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Levothyroxine | Levothyroxine The therapeutic efficacy of Levothyroxine can be increased when used in combination with Sulfasalazine. |
Liothyronine | Liothyronine Sulfasalazine may decrease the excretion rate of Liothyronine which could result in a higher serum level. |
Methimazole | Methimazole The risk or severity of adverse effects can be increased when Methimazole is combined with Sulfasalazine. |
Propylthiouracil | Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Sulfasalazine. |
Chlorpropamide | Chlorpropamide Sulfasalazine may increase the hypoglycemic activities of Chlorpropamide. |
Tolbutamide | Tolbutamide Sulfasalazine may increase the hypoglycemic activities of Tolbutamide. |
Tolazamide | Tolazamide Sulfasalazine may increase the hypoglycemic activities of Tolazamide. |
Dinoprostone | Dinoprostone The excretion of Dinoprostone can be decreased when combined with Sulfasalazine. |
Baclofen | Baclofen Sulfasalazine may decrease the excretion rate of Baclofen which could result in a higher serum level. |
Ethambutol | Ethambutol Sulfasalazine may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Sulfasalazine. |
Hydrochlorothiazide | Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Sulfasalazine. |
Dantrolene | Dantrolene The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Dantrolene. |
Chlorzoxazone | Chlorzoxazone Sulfasalazine may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level. |
Pyridoxine | Pyridoxine Sulfasalazine may decrease the excretion rate of Pyridoxine which could result in a higher serum level. |
Folic Acid | Folic Acid The serum concentration of Folic acid can be decreased when it is combined with Sulfasalazine. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Sulfasalazine may decrease the antihypertensive activities of Propranolol. |
Minoxidil | Minoxidil The therapeutic efficacy of Minoxidil can be decreased when used in combination with Sulfasalazine. |
Pseudoephedrine | Pseudoephedrine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Pseudoephedrine. |
Nortriptyline | Nortriptyline The risk or severity of hypertension can be increased when Nortriptyline is combined with Sulfasalazine. |
Spironolactone | Spironolactone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Spironolactone. |
Amphotericin B Injection | Amphotericin B Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Sulfasalazine. |
Mercaptopurine | Mercaptopurine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mercaptopurine. |
Phytonadione | Phytonadione Sulfasalazine may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Sulfasalazine may decrease the excretion rate of Amikacin which could result in a higher serum level. |
Nadolol | Nadolol Sulfasalazine may decrease the antihypertensive activities of Nadolol. |
Cholestyramine Resin | Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Allopurinol | Allopurinol Sulfasalazine may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Flavoxate | Flavoxate Sulfasalazine may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Sulfasalazine. |
Colchicine | Colchicine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Colchicine. |
Cefaclor | Cefaclor Sulfasalazine may decrease the excretion rate of Cefaclor which could result in a higher serum level. |
Cefadroxil | Cefadroxil Sulfasalazine may decrease the excretion rate of Cefadroxil which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefazolin. |
Cephalexin | Cephalexin Sulfasalazine may decrease the excretion rate of Cephalexin which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefoxitin. |
Dacarbazine | Dacarbazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dacarbazine. |
Acetazolamide | Acetazolamide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Acetazolamide. |
Cefotaxime Injection | Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Sulfasalazine. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Sulfasalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level. |
Bacillus Calmette-Guerin (BCG) Vaccine | Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Sulfasalazine. |
Ketoconazole | Ketoconazole The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Ketoconazole. |
Pyrantel | Pyrantel Sulfasalazine may decrease the excretion rate of Pyrantel which could result in a higher serum level. |
Thiotepa Injection | Thiotepa Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Thiotepa. |
Vincristine Injection | Vincristine Injection The risk or severity of adverse effects can be increased when Vincristine is combined with Sulfasalazine. |
Captopril | Captopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Captopril. |
Dipyridamole | Dipyridamole The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Dipyridamole. |
Isoxsuprine | Isoxsuprine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Isoxsuprine. |
Vinblastine | Vinblastine The risk or severity of adverse effects can be increased when Vinblastine is combined with Sulfasalazine. |
Ethacrynic Acid | Ethacrynic Acid The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Sulfasalazine. |
Colistimethate Injection | Colistimethate Injection The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Colistimethate. |
Metoprolol | Metoprolol Sulfasalazine may decrease the antihypertensive activities of Metoprolol. |
Aspirin | Aspirin The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Sulfasalazine. |
Salsalate | Salsalate The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Salsalate. |
Chlorambucil | Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Sulfasalazine. |
Alprazolam | Alprazolam Sulfasalazine may decrease the excretion rate of Alprazolam which could result in a higher serum level. |
Temazepam | Temazepam Sulfasalazine may decrease the excretion rate of Temazepam which could result in a higher serum level. |
Triazolam | Triazolam Sulfasalazine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
Dicyclomine | Dicyclomine Sulfasalazine may decrease the excretion rate of Dicyclomine which could result in a higher serum level. |
Propantheline | Propantheline Sulfasalazine may decrease the excretion rate of Propantheline which could result in a higher serum level. |
Trimethoprim | Trimethoprim Sulfasalazine may decrease the excretion rate of Trimethoprim which could result in a higher serum level. |
Diltiazem | Diltiazem The risk or severity of bleeding can be increased when Diltiazem is combined with Sulfasalazine. |
Nifedipine | Nifedipine Sulfasalazine may decrease the excretion rate of Nifedipine which could result in a higher serum level. |
Timolol | Timolol Sulfasalazine may decrease the antihypertensive activities of Timolol. |
Verapamil | Verapamil The risk or severity of bleeding can be increased when Verapamil is combined with Sulfasalazine. |
Atenolol | Atenolol Sulfasalazine may decrease the antihypertensive activities of Atenolol. |
Pindolol | Pindolol Sulfasalazine may decrease the antihypertensive activities of Pindolol. |
Cisplatin Injection | Cisplatin Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Cisplatin. |
Diflunisal | Diflunisal The therapeutic efficacy of Diflunisal can be decreased when used in combination with Sulfasalazine. |
Piroxicam | Piroxicam The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Piroxicam. |
Bumetanide | Bumetanide The therapeutic efficacy of Bumetanide can be decreased when used in combination with Sulfasalazine. |
Streptozocin | Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Sulfasalazine. |
Etoposide | Etoposide The risk or severity of adverse effects can be increased when Etoposide is combined with Sulfasalazine. |
Glyburide | Glyburide Sulfasalazine may increase the hypoglycemic activities of Glyburide. |
Glipizide | Glipizide Sulfasalazine may increase the hypoglycemic activities of Glipizide. |
Indapamide | Indapamide The therapeutic efficacy of Indapamide can be decreased when used in combination with Sulfasalazine. |
Amoxicillin | Amoxicillin Sulfasalazine may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Sulfasalazine may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline The risk or severity of bleeding can be increased when Sulfasalazine is combined with Pentoxifylline. |
Pentamidine Injection | Pentamidine Injection Sulfasalazine may increase the hypoglycemic activities of Pentamidine. |
Ceftriaxone Injection | Ceftriaxone Injection Sulfasalazine may decrease the excretion rate of Ceftriaxone which could result in a higher serum level. |
Labetalol | Labetalol Sulfasalazine may decrease the antihypertensive activities of Labetalol. |
Auranofin | Auranofin Sulfasalazine may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection Sulfasalazine may decrease the excretion rate of Leuprolide which could result in a higher serum level. |
Gemfibrozil | Gemfibrozil Sulfasalazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Guanabenz | Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Sulfasalazine. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Sulfasalazine. |
Ceftazidime Injection | Ceftazidime Injection Sulfasalazine may decrease the excretion rate of Ceftazidime which could result in a higher serum level. |
Ketoprofen | Ketoprofen The risk or severity of bleeding and gastrointestinal bleeding can be increased when Sulfasalazine is combined with Ketoprofen. |
Cefotetan Injection | Cefotetan Injection Sulfasalazine may decrease the excretion rate of Cefotetan which could result in a higher serum level. |
Enalapril | Enalapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Enalapril. |
Flurbiprofen | Flurbiprofen The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Flurbiprofen. |
Amiodarone | Amiodarone The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Amiodarone. |
Aztreonam Injection | Aztreonam Injection Sulfasalazine may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone Sulfasalazine may decrease the excretion rate of Buspirone which could result in a higher serum level. |
Lovastatin | Lovastatin The excretion of Lovastatin can be decreased when combined with Sulfasalazine. |
Ciprofloxacin | Ciprofloxacin Sulfasalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. |
Mesalamine | Mesalamine The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Mesalazine. |
Diclofenac | Diclofenac The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Diclofenac. |
Fluoxetine | Fluoxetine The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Sulfasalazine. |
Nimodipine | Nimodipine The therapeutic efficacy of Nimodipine can be decreased when used in combination with Sulfasalazine. |
Interferon Alfa-2b Injection | Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Sulfasalazine. |
Clozapine | Clozapine Sulfasalazine may decrease the excretion rate of Clozapine which could result in a higher serum level. |
Estazolam | Estazolam Sulfasalazine may decrease the excretion rate of Estazolam which could result in a higher serum level. |
Idarubicin | Idarubicin The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Idarubicin. |
Ofloxacin | Ofloxacin Sulfasalazine may increase the neuroexcitatory activities of Ofloxacin. |
Didanosine | Didanosine Sulfasalazine may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Fludarabine Injection | Fludarabine Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fludarabine. |
Pentostatin Injection | Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Sulfasalazine. |
Benazepril | Benazepril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Benazepril. |
Etodolac | Etodolac The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Etodolac. |
Felodipine | Felodipine The therapeutic efficacy of Felodipine can be decreased when used in combination with Sulfasalazine. |
Fosinopril | Fosinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Fosinopril. |
Nabumetone | Nabumetone The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Nabumetone. |
Pravastatin | Pravastatin Pravastatin may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Quinapril | Quinapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Quinapril. |
Ramipril | Ramipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Ramipril. |
Simvastatin | Simvastatin The excretion of Simvastatin can be decreased when combined with Sulfasalazine. |
Amlodipine | Amlodipine Sulfasalazine may decrease the antihypertensive activities of Amlodipine. |
Teniposide Injection | Teniposide Injection The risk or severity of adverse effects can be increased when Teniposide is combined with Sulfasalazine. |
Itraconazole | Itraconazole The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Itraconazole. |
Lisinopril | Lisinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Lisinopril. |
Oxaprozin | Oxaprozin The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Oxaprozin. |
Sotalol | Sotalol Sulfasalazine may decrease the antihypertensive activities of Sotalol. |
Bisoprolol | Bisoprolol Sulfasalazine may decrease the antihypertensive activities of Bisoprolol. |
Doxazosin | Doxazosin The therapeutic efficacy of Doxazosin can be decreased when used in combination with Sulfasalazine. |
Terazosin | Terazosin The therapeutic efficacy of Terazosin can be decreased when used in combination with Sulfasalazine. |
Isradipine | Isradipine Sulfasalazine may decrease the excretion rate of Isradipine which could result in a higher serum level. |
Omeprazole | Omeprazole Omeprazole may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Fluvastatin | Fluvastatin The excretion of Fluvastatin can be decreased when combined with Sulfasalazine. |
Venlafaxine | Venlafaxine Venlafaxine may increase the antiplatelet activities of Sulfasalazine. |
Fluvoxamine | Fluvoxamine The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Fluvoxamine. |
Nefazodone | Nefazodone The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Nefazodone. |
Lamotrigine | Lamotrigine Sulfasalazine may decrease the excretion rate of Lamotrigine which could result in a higher serum level. |
Losartan | Losartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Sulfasalazine. |
Valacyclovir | Valacyclovir Sulfasalazine may decrease the excretion rate of Valaciclovir which could result in a higher serum level. |
Tramadol | Tramadol Sulfasalazine may decrease the excretion rate of Tramadol which could result in a higher serum level. |
Vinorelbine Injection | Vinorelbine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Sulfasalazine. |
Carboplatin Injection | Carboplatin Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Carboplatin. |
Moexipril | Moexipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Moexipril. |
Lansoprazole | Lansoprazole Lansoprazole may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Ifosfamide Injection | Ifosfamide Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ifosfamide. |
Pegaspargase Injection | Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Sulfasalazine. |
Nicardipine | Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Sulfasalazine. |
Bupropion | Bupropion Sulfasalazine may decrease the excretion rate of Bupropion which could result in a higher serum level. |
Ticlopidine | Ticlopidine The risk or severity of bleeding can be increased when Sulfasalazine is combined with Ticlopidine. |
Saquinavir | Saquinavir Saquinavir may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Metformin | Metformin Sulfasalazine may increase the hypoglycemic activities of Metformin. |
Dalteparin Injection | Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Dalteparin. |
Nisoldipine | Nisoldipine Sulfasalazine may decrease the excretion rate of Nisoldipine which could result in a higher serum level. |
Lamivudine | Lamivudine Sulfasalazine may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Riluzole | Riluzole Sulfasalazine may decrease the excretion rate of Riluzole which could result in a higher serum level. |
Acarbose | Acarbose Sulfasalazine may increase the hypoglycemic activities of Acarbose. |
Glimepiride | Glimepiride Sulfasalazine may increase the hypoglycemic activities of Glimepiride. |
Gemcitabine Injection | Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Sulfasalazine. |
Ritonavir | Ritonavir Ritonavir may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Docetaxel Injection | Docetaxel Injection The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Docetaxel. |
Cidofovir Injection | Cidofovir Injection Sulfasalazine may decrease the excretion rate of Cidofovir which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Sulfasalazine may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine Sulfasalazine may decrease the excretion rate of Clomipramine which could result in a higher serum level. |
Fosfomycin | Fosfomycin Sulfasalazine may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Mirtazapine | Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Sulfasalazine. |
Trandolapril | Trandolapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Trandolapril. |
Topiramate | Topiramate Sulfasalazine may decrease the excretion rate of Topiramate which could result in a higher serum level. |
Valsartan | Valsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Sulfasalazine. |
Insulin Lispro Injection | Insulin Lispro Injection Sulfasalazine may increase the hypoglycemic activities of Insulin lispro. |
Pramipexole | Pramipexole Sulfasalazine may decrease the excretion rate of Pramipexole which could result in a higher serum level. |
Donepezil | Donepezil Sulfasalazine may decrease the excretion rate of Donepezil which could result in a higher serum level. |
Nelfinavir | Nelfinavir Nelfinavir may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Fexofenadine | Fexofenadine The excretion of Fexofenadine can be decreased when combined with Sulfasalazine. |
Carvedilol | Carvedilol Sulfasalazine may decrease the antihypertensive activities of Carvedilol. |
Nilutamide | Nilutamide Sulfasalazine may decrease the excretion rate of Nilutamide which could result in a higher serum level. |
Flutamide | Flutamide The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Flutamide. |
Selegiline | Selegiline The risk or severity of hypertension can be increased when Sulfasalazine is combined with Selegiline. |
Sertraline | Sertraline The risk or severity of bleeding can be increased when Sertraline is combined with Sulfasalazine. |
Propafenone | Propafenone Sulfasalazine may decrease the antihypertensive activities of Propafenone. |
Raloxifene | Raloxifene Sulfasalazine may decrease the excretion rate of Raloxifene which could result in a higher serum level. |
Irbesartan | Irbesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Sulfasalazine. |
Tamsulosin | Tamsulosin Sulfasalazine may decrease the excretion rate of Tamsulosin which could result in a higher serum level. |
Finasteride | Finasteride The risk or severity of hypertension can be increased when Sulfasalazine is combined with Finasteride. |
Quetiapine | Quetiapine Sulfasalazine may decrease the excretion rate of Quetiapine which could result in a higher serum level. |
Cefepime Injection | Cefepime Injection The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefepime. |
Cefprozil | Cefprozil The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefprozil. |
Cefpodoxime | Cefpodoxime The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefpodoxime. |
Cetirizine | Cetirizine Sulfasalazine may decrease the excretion rate of Cetirizine which could result in a higher serum level. |
Paroxetine | Paroxetine The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Sulfasalazine. |
Tolcapone | Tolcapone Sulfasalazine may decrease the excretion rate of Tolcapone which could result in a higher serum level. |
Citalopram | Citalopram The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Sulfasalazine. |
Capecitabine | Capecitabine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Capecitabine. |
Abacavir | Abacavir Sulfasalazine may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Pioglitazone | Pioglitazone Sulfasalazine may increase the hypoglycemic activities of Pioglitazone. |
Trastuzumab Injection | Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Sulfasalazine. |
Celecoxib | Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Sulfasalazine. |
Rosiglitazone | Rosiglitazone Sulfasalazine may increase the hypoglycemic activities of Rosiglitazone. |
Tolterodine | Tolterodine Sulfasalazine may decrease the excretion rate of Tolterodine which could result in a higher serum level. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Thalidomide. |
Oseltamivir | Oseltamivir Sulfasalazine may decrease the excretion rate of Oseltamivir which could result in a higher serum level. |
Colesevelam | Colesevelam Colesevelam can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
Balsalazide | Balsalazide The therapeutic efficacy of Balsalazide can be decreased when used in combination with Sulfasalazine. |
Nateglinide | Nateglinide Sulfasalazine may increase the hypoglycemic activities of Nateglinide. |
Rabeprazole | Rabeprazole Rabeprazole may decrease the excretion rate of Sulfasalazine which could result in a higher serum level. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists